GlassScriptPhysician profile
Zoe A Textoris
NPI 1154953289
$2,263.25
in general payments reported to CMS, 2019-2025
25 companies · $562 in 2025
The $562 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $773 · 2022: $364 · 2023: $487 · 2024: $77.40 · 2025: $562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,126.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $324.48 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Stryker Corporation | $280.38 | 2025 | Universal Neuro 3, N/A |
| Astrazeneca Pharmaceuticals LP | $271.37 | 2021 | |
| Boston Scientific Corporation | $186.67 | 2022-2023 | Infinion 16 |
| Integra Lifesciences Corporation | $159.59 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Novo Nordisk INC | $153.40 | 2021-2022 | |
| Providence Medical Technology, INC. | $149.10 | 2023 | |
| Sanofi-Aventis U.S. LLC | $124.93 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $113.37 | 2022 | |
| Ethicon US, LLC | $71.34 | 2023-2025 | Dermabond Prineo, Stratafix |
| Abbvie INC. | $64.76 | 2021-2023 | |
| Augmedics INC. | $64.42 | 2023 | Xvision |
| Amarin Pharma, INC. | $53.06 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $35.12 | 2021 | |
| Esperion Therapeutics, INC. | $30.96 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $30.60 | 2021 | |
| Lilly USA, LLC | $25.27 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.35 | 2021 | |
| Astellas Pharma US INC | $18.38 | 2021 | |
| Solventum Corporation | $18.02 | 2025 | Prevena |
| Currax Pharmaceuticals LLC | $14.59 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.94 | 2022 | |
| Almatica Pharma LLC | $12.98 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.74 | 2022 | |
| Dexcom, INC. | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zoe Textoris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.